S&P Cuts Biogen to Avoid

Also: analysts' opinions on RF Micro Devices and Merrill Lynch

Biogen (BGEN ): Downgrades to 2 STARS (avoid) from 4 STARS (accumulate)

To continue reading this article you must be a Bloomberg Professional Service Subscriber.